Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Novartis Pharma B.V
Woman and Man Max 99 years
Novartis Pharma B.V
Update Il y a 4 ans
Angiotensin II receptor blockers in patients with systemic right ventricle
The primary objective of this study is to determine whether Angiotensin II Receptor Blockers (valsartan) improve the functional (contractile, electrophysiologic) performance of the right ventricle in ...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Novartis Pharma B.V. (The Netherlands)
Update Il y a 4 ans
An open label randomised controlled study in elderly subjects with previously untreated acute myelogenous leukaemia, comparing treatment groups randomised to receive daunorubicin and cytarabine or daunorubicin, cytarabine and PSC-833
Not provided at time of registration
Country
Netherlands
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Novartis Pharma B.V. (The Netherlands)
Update Il y a 4 ans
Effect of recombinant Granulocyte Colony-Stimulating Factor (G-CSF) on the results of chemotherapy (CHOP) in elderly patients with intermediate-/high-grade Non-Hodgkin's Lymphoma: a prospective phase III study
Not provided at time of registration
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Novartis Pharma B.V. (The Netherlands)
Update Il y a 4 ans
Myfortic® versus Neoral® as long-term treatment in patients with severe atopic dermatitis: a randomised-controlled trial
Not provided at time of registration
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Novartis Pharma B.V. (The Netherlands)
Update Il y a 4 ans
A phase II study to investigate the effect of Glivec® (imatinib mesylate, formerly known as STI571) in patients with inoperable medullary thyroid carcinoma
Not provided at time of registration
Country
None
organs
None
Specialty
None
Closed trial
More information